The burden and risks of emerging complications of diabetes mellitus

D Tomic, JE Shaw, DJ Magliano - Nature Reviews Endocrinology, 2022 - nature.com
The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

[HTML][HTML] Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence

C Wagner, M Griesel, A Mikolajewska… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …

Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes

OS Janjua, MS Shaikh, MA Fareed, SM Qureshi… - Journal of Fungi, 2021 - mdpi.com
It has been nearly two years since the pandemic caused by the novel coronavirus disease
(COVID-19) has affected the world. Several innovations and discoveries related to COVID …

[HTML][HTML] The World Health Organization (WHO) fungal priority pathogens list in response to emerging fungal pathogens during the COVID-19 pandemic

DV Parums - … science monitor: international medical journal of …, 2022 - ncbi.nlm.nih.gov
The COVID-19 pandemic, climate change, increased resistance to antifungal drugs, and an
increased number of immunocompromised patients have driven a recent global surge in …

Systemic corticosteroids for the treatment of COVID‐19

Cochrane Haematology Group… - Cochrane Database …, 1996 - cochranelibrary.com
Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …

Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion

Z Qin, A Bouteau, C Herbst, BZ Igyártó - PLoS Pathogens, 2022 - journals.plos.org
Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been
administered to humans. However, we lack a comprehensive understanding of the immune …

[HTML][HTML] Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach

A Azhar, WH Khan, PA Khan, K Alhosaini… - Journal of Infection and …, 2022 - Elsevier
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
yet to be controlled worldwide, especially in India. The second wave of coronavirus disease …

In silico evaluation of antifungal compounds from marine sponges against COVID-19-associated mucormycosis

O Pokharkar, H Lakshmanan, G Zyryanov, M Tsurkan - Marine Drugs, 2022 - mdpi.com
The world is already facing the devastating effects of the SARS-CoV-2 pandemic. A
disseminated mucormycosis epidemic emerged to worsen this situation, causing havoc …

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity

C Iwamura, K Hirahara, M Kiuchi… - Proceedings of the …, 2022 - National Acad Sciences
The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary
vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review

NN Shah, Z Khan, H Ahad, AY Elderdery… - Journal of infection and …, 2022 - Elsevier
Abstract As of 25th July, 2022, global Disease burden of 575,430,244 confirmed cases and
over 6,403,511 deaths have been attributed to coronavirus disease 2019 (COVID-19). Co …